Alligator Bioscience AB Interim Report January-September 2018
The science behind the Nobel Prizes in Medicine and Chemistry constitutes the core in Alligator’s research and development.Significant events July-September • Preclinical development of ATOR-1015 completed. Application for Clinical Trial Authorization submitted. • New preclinical data supports the favorable safety profile of the 4-1BB antibody ATOR-1017. Events after the end of the period • James P. Allison and Tasuku Honjo to receive the Nobel Prize for their pioneering work in cancer immunotherapy, directly linked to ATOR-1015. • Frances H. Arnold, George P. Smith and Sir